anonymous
Guest
anonymous
Guest
You know this is probably a once in a lifetime opportunity. I can appreciate why you might wanna know some of the nuances around compensation, but seriously if you’re asking about the drug you don’t know much. The product is excellent. There’s a huge unmet need, and we’re just about ready to get outcomes data in the label which will not only garner a 300 million payment from the Japanese, but also gave us a huge leg up to move forward here in the great United States of America. It’s a no brainer.